סואנוביל 20 וטרינרי
beit-erez havat milatin ltd - spiramycin - תמיסה להזרקה - spiramycin 600000 iu/ml
אפקסור xr 75
pfizer pfe pharmaceuticals israel ltd - venlafaxine as hydrochloride - קפסולות בשחרור נרחב - venlafaxine as hydrochloride 75 mg - venlafaxine - venlafaxine - for the treatment of depression. maintenance of recurrent depression. generalized anxiety disorder (gad) - short term and long-term. social anxiety disorder (sad).
אפקסור xr 150
pfizer pfe pharmaceuticals israel ltd - venlafaxine as hydrochloride - קפסולות בשחרור נרחב - venlafaxine as hydrochloride 150 mg - venlafaxine - venlafaxine - for the treatment of depression. maintenance of recurrent depression. generalized anxiety disorder (gad) - short term and long-term. social anxiety disorder (sad).
אפקסור xr 150
pfizer pfe pharmaceuticals israel ltd - venlafaxine as hydrochloride - קפסולות בשחרור נרחב - venlafaxine as hydrochloride 150 mg - venlafaxine
אפקסור xr 75
pfizer pfe pharmaceuticals israel ltd - venlafaxine as hydrochloride - קפסולות בשחרור נרחב - venlafaxine as hydrochloride 75 mg - venlafaxine
אקינזאו
rafa laboratories ltd - netupitant; palonosetron as hydrochloride - קפסולות - netupitant 300 mg; palonosetron as hydrochloride 0.50 mg - palonosetron, combinations
פרוויג'יל
abic marketing ltd, israel - modafinil - קפליות - modafinil 100 mg - modafinil
פרוויג'יל
abic marketing ltd, israel - modafinil - קפליות - modafinil 100 mg - modafinil
אקטיק 200 מקג
abic marketing ltd, israel - fentanyl as citrate - טבליות דחוסות על מקל - fentanyl as citrate 200 mcg/dose - fentanyl - fentanyl - actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.
אקטיק 600 מקג
abic marketing ltd, israel - fentanyl as citrate - טבליות דחוסות על מקל - fentanyl as citrate 600 mcg/dose - fentanyl - fentanyl - actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.